-
EP4301859
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4301859
| EP4301859 - ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 08.12.2023 Database last updated on 24.08.2024 | |
| Former | The international publication has been made Status updated on 09.09.2022 | Most recent event Tooltip | 10.05.2024 | Change: Validation states | published on 12.06.2024 [2024/24] | 10.05.2024 | Change - extension states | published on 12.06.2024 [2024/24] | Applicant(s) | For all designated states Code Biotherapeutics, Inc. 2801 Sterling Drive Hatfield, PA 19440 / US | For all designated states University of Maryland, College Park UM Ventures 0134 Lee Building 7809 Regents Drive College Park, MD 20742 / US | [2024/02] | Inventor(s) | 01 /
MURO, Silvia Gaithersburg, MD 20878 / US | 02 /
ROKI, Niksa Lewis Center, OH 43035 / US | 03 /
GETTS, Robert Hatfield, PA 19440 / US | [2024/02] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2024/02] | Application number, filing date | 22764114.9 | 04.03.2022 | [2024/02] | WO2022US18855 | Priority number, date | US202163156869P | 04.03.2021 Original published format: US 202163156869 P | [2024/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022187586 | Date: | 09.09.2022 | Language: | EN | [2022/36] | Type: | A1 Application with search report | No.: | EP4301859 | Date: | 10.01.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.09.2022 takes the place of the publication of the European patent application. | [2024/02] | Search report(s) | International search report - published on: | US | 09.09.2022 | Classification | IPC: | C12N15/115, C07K17/02, A61K47/42 | [2024/02] | CPC: |
C07K19/00 (EP);
A61K47/42 (EP);
A61K47/6807 (EP);
A61K47/6849 (EP);
A61K9/0019 (EP);
A61P17/02 (EP);
A61P35/00 (EP);
C07K16/2821 (EP);
A61K2039/505 (EP);
C07K2317/40 (EP);
C07K2317/92 (EP);
C07K2317/94 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/02] | Title | German: | VERBESSERTES TARGETING MIT ANTIKÖRPER-OLIGONUKLEOTID-KONJUGATEN | [2024/02] | English: | ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES | [2024/02] | French: | CIBLAGE AMÉLIORÉ À L'AIDE DE CONJUGUÉS ANTICORPS-OLIGONUCLÉOTIDE | [2024/02] | Entry into regional phase | 04.10.2023 | National basic fee paid | 04.10.2023 | Search fee paid | 04.10.2023 | Designation fee(s) paid | 04.10.2023 | Examination fee paid | Examination procedure | 04.10.2023 | Examination requested [2024/02] | 23.04.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 04.10.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2019152571 (MERCK SHARP & DOHME [US], et al) [Y] 2-15* abstract, pg 6, In 7-17, pg 11, In 5-17, pg 11, In 20-21, pg 33, In 5-9, pg 33, In 10-14, pg 40, In 29-33, pg 40, in 34-36 *; | [XY] - Margherita Passariello; Simona Camorani; Cinzia Vetrei; Laura Cerchia; Claudia De Lorenzo, "Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing", Cancers, (20190000), vol. 11, no. 1268, pages 1 - 20, XP055741168 [X] 1 * . Especially abstract, pg 7, para 3, pg 10, para 1, pg 12, para 4 * [Y] 2-15 DOI: http://dx.doi.org/10.3390/cancers11091268 |